GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » MustGrow Biologics Corp (TSXV:MGRO) » Definitions » Cash And Cash Equivalents

MustGrow Biologics (TSXV:MGRO) Cash And Cash Equivalents : C$5.89 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is MustGrow Biologics Cash And Cash Equivalents?

MustGrow Biologics's quarterly cash and cash equivalents increased from Sep. 2023 (C$4.17 Mil) to Dec. 2023 (C$6.82 Mil) but then stayed the same from Dec. 2023 (C$6.82 Mil) to Mar. 2024 (C$5.89 Mil).

MustGrow Biologics's annual cash and cash equivalents declined from Dec. 2021 (C$9.62 Mil) to Dec. 2022 (C$7.02 Mil) and declined from Dec. 2022 (C$7.02 Mil) to Dec. 2023 (C$6.82 Mil).


MustGrow Biologics Cash And Cash Equivalents Historical Data

The historical data trend for MustGrow Biologics's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MustGrow Biologics Cash And Cash Equivalents Chart

MustGrow Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial 4.03 3.31 9.62 7.02 6.82

MustGrow Biologics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.02 6.10 4.17 6.82 5.89

MustGrow Biologics Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


MustGrow Biologics  (TSXV:MGRO) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


MustGrow Biologics Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of MustGrow Biologics's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


MustGrow Biologics (TSXV:MGRO) Business Description

Traded in Other Exchanges
Address
1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a company engaged in the development of natural biopesticide products from mustard seed. It is focused on the development and commercialization of non-synthetic AITC (Allyl Isothiocyanate) from mustard seed for use as a natural biofumigant for the control of nematodes, soil-borne diseases, and other soil pests.
Executives
Corey Joseph Giasson Director, Senior Officer
Colin Michael Bletsky Director

MustGrow Biologics (TSXV:MGRO) Headlines

No Headlines